263 related articles for article (PubMed ID: 1969865)
1. Multidrug resistance due to P-glycoprotein.
Burt RK; Fojo AT; Thorgeirsson SS
Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
Chabner BA; Fojo A
J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356
[No Abstract] [Full Text] [Related]
3. Multidrug resistance in human cancer.
Goldstein LJ; Pastan I; Gottesman MM
Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
[No Abstract] [Full Text] [Related]
4. Drug resistance and cancer.
Morrow CS; Cowan K
Adv Exp Med Biol; 1993; 330():287-305. PubMed ID: 8103619
[No Abstract] [Full Text] [Related]
5. P glycoprotein (P-gp) and drug resistance--time for reappraisal?
Kaye SB
Br J Cancer; 1993 Apr; 67(4):641-3. PubMed ID: 8097103
[No Abstract] [Full Text] [Related]
6. Multidrug resistance: molecular biology and clinical relevance.
Rothenberg M; Ling V
J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
[No Abstract] [Full Text] [Related]
7. Multidrug resistance in leukemia.
Rischin D; Ling V
Cancer Treat Res; 1993; 64():269-93. PubMed ID: 8095795
[No Abstract] [Full Text] [Related]
8. Multidrug resistance: a novel class of membrane-associated transport proteins is identified.
Gros P; Shustik C
Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020
[No Abstract] [Full Text] [Related]
9. Mechanism of multidrug resistance.
Bradley G; Juranka PF; Ling V
Biochim Biophys Acta; 1988 Aug; 948(1):87-128. PubMed ID: 2899442
[No Abstract] [Full Text] [Related]
10. Multidrug resistance.
Tiirikainen MI; Krusius T
Ann Med; 1991; 23(5):509-20. PubMed ID: 1684512
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
Huang CC; Wu MC; Xu GW; Li DZ; Cheng H; Tu ZX; Jiang HQ; Gu JR
J Natl Cancer Inst; 1992 Feb; 84(4):262-4. PubMed ID: 1346405
[No Abstract] [Full Text] [Related]
12. Genetic aspects of multidrug resistance.
Pauly M; Ries F; Dicato M
Med Oncol Tumor Pharmacother; 1992; 9(1):21-4. PubMed ID: 1364127
[TBL] [Abstract][Full Text] [Related]
13. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
14. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs.
Ling V
Cancer; 1992 May; 69(10):2603-9. PubMed ID: 1348966
[No Abstract] [Full Text] [Related]
15. Multidrug resistance in human tumors.
Bellamy WT
Curr Opin Oncol; 1990 Dec; 2(6):1126-32. PubMed ID: 1983090
[No Abstract] [Full Text] [Related]
16. Multidrug resistance and P-glycoprotein expression in human cancer.
Ma DD; Bell DR
Aust N Z J Med; 1989 Dec; 19(6):736-43. PubMed ID: 2576624
[No Abstract] [Full Text] [Related]
17. [Multiple drug resistance: a problem in cancer chemotherapy].
Lizano Soberón M; Barrera Rodríquez R
Rev Invest Clin; 1993; 45(5):481-92. PubMed ID: 7907810
[TBL] [Abstract][Full Text] [Related]
18. The clinical relevance of multidrug resistance.
Bellamy WT; Dalton WS; Dorr RT
Cancer Invest; 1990; 8(5):547-62. PubMed ID: 1979932
[No Abstract] [Full Text] [Related]
19. Is the multidrug transporter a flippase?
Higgins CF; Gottesman MM
Trends Biochem Sci; 1992 Jan; 17(1):18-21. PubMed ID: 1374941
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and multidrug resistance.
Kruh GD; Goldstein LJ
Curr Opin Oncol; 1993 Nov; 5(6):1029-34. PubMed ID: 7905750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
